BioSpace News Archive

Drug Development

ChemomAb Doses First Patient in Phase 1b Clinical trial of CM-101 in Patients With Non-Alcoholic Fatty Liver Disease

ChemomAb announced dosing of the first patient in a Phase 1b repeated dose clinical trial with CM-101 in non-alcoholic fatty liver disease (NAFLD) patients.

January 10, 2019
·
2 min read
Drug Development

Acceleron Announces Publication of Luspatercept Phase 2 Beta-Thalassemia Study Results in Blood

Acceleron Pharma Inc. today announced that the journal Blood has published results from the Phase 2 study of luspatercept in patients with red blood cell (RBC) transfusion-dependent and non-transfusion-dependent beta-thalassemia.

January 10, 2019
·
6 min read
Deals

Premier Health Signs Definitive Agreement for Acquisition of Cloud Practice Inc., a National Medical Software Application Company

Premier Health Group Inc. (CSE: PHGI) (OTCQB: PHGRF) (Frankfurt: 6PH) (the “Company” or “Premier Health”), is pleased to announce, further to its news release dated December 17, 2018, the Company has signed a Definitive Agreement (“the Agreement”) to acquire all of the outstanding securities of Cloud Practice Inc. (“Cloud Practice”).

January 10, 2019
·
5 min read
Business

GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology

GigaGen Inc., a biopharmaceutical company developing novel antibody therapies, today announced that Erica Stone, Ph.D., has joined the company as director, immuno-oncology.

January 10, 2019
·
2 min read
Drug Development

Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-1287 in Phase 1 Study in Patients with Advanced Solid Tumors

Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that the first patient has been dosed in a Phase 1 study evaluating the investigational agent TP-1287,

January 10, 2019
·
2 min read
Business

c-LEcta Announces Two Long-Term Industry Collaborations

Strategic cooperation agreements finalized with two industrial companies

January 10, 2019
·
2 min read
Policy

R&D biopharmaceutical industry embraces NEW Code of Practice to boost business integrity worldwide

The new Code of Practice in place from 1 January 2019, imposes a complete ban on gifts and promotional aids

January 10, 2019
·
4 min read
Business

‘American Ninja Warrior’ Finalist ‘The Flying Phoenix’ Najee Richardson Joins American Lung Association Fight For Air Climbs in Five Cities

-Today, the American Lung Association announced the dates and locations of five Fight For Air Climbs where American Ninja Warrior TV series finalist and National Fight For Air Climb Ambassador Najee Richardson will appear across the country.

January 10, 2019
·
3 min read
Deals

genae Buys MedicSense

genae, Experts in Value-driven Science & Technology for the Medical Industries, today announced the acquisition of MedicSense, a Clinical, Regulatory Affairs and Quality Assurance consultancy firm

January 10, 2019
·
1 min read
BioMidwest

McCormick Foundation, Major League Baseball Announces Final Grants for Welcome Back Veterans

The Robert R. McCormick Foundation, in partnership with Major League Baseball, awarded the final round of grants from the Welcome Back Veterans (WBV) initiative totaling nearly $1.8 million dollars.

January 10, 2019
·
4 min read